Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

zhejiang jingwei pharmaceutical co., ltd. - phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv), mineral oil (unii: t5l8t28fgp) (mineral oil - unii:t5l8t28fgp), petrolatum (unii: 4t6h12bn9u) (petrolatum - unii:4t6h12bn9u) - purposes --- protectant ---protectant ---vasoconstrictor uses - helps relieve the local itching and discomfort associated with hemorrhoids. -temporarily shrinks hemorrhoid tissue and relieves burning -temporarily provides a coating for relief of anorectal discomforts -temporarily protects the inflamed, irritated anorectal surface to help make bowel movements less painful stop use and ask a doctor if -bleeding occurs -condition worsens or does not improve within 7 days. -introduction of the appllicator into the rectum causes additional pain

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

zhejiang jingwei pharmaceutical co., ltd. - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - purpose topical analgesic uses  for temporary relief of pain associated with - minor burns - sunburn - minor cuts or scrapes - minor skin irritations do not use - in large quantities, particularly over raw surfaces or blistered areas stop use and ask a doctor if - if condition worsens, or if symptoms persist for more than 7 days or clear up and then occur again within a few days, discontinue use of this product and consult a physician

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

zhejiang jingwei pharmaceutical co., ltd. - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987) - purpose topical analgesic    temporarily relieves pain, itching and irritation. uses do not use -before any hair removal process that involves heat or lasers -in large quantities, particularly over raw surfaces or blistered areas stop use and ask a doctor if -symptoms persist for more than 7 days or clear up and occur again within a few days -condition worsens -redness is present -irritation develops

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

zhejiang jingwei pharmaceutical co., ltd. - glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv), pramoxine hydrochloride (unii: 88ayb867l5) (pramoxine - unii:068x84e056), petrolatum (unii: 4t6h12bn9u) (petrolatum - unii:4t6h12bn9u) - purpose protectant vasoconstrictor local anesthetic protectant uses - for temporary relief of pain, soreness and burning - helps relieve the local itching and discomfort associated with hemorrhoids - temporarily shrinks hemorrhoidal tissue - temporarily provides a coating for relief of anorectal discomforts - temporarily protects the inflamed, irritated anorectal surface to help make bowel movements less painful

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

zhejiang jingwei pharmaceutical co., ltd. - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - purpose anti-itch uses - for temporary relief of itching associated with minor skin irritations, inflammation and rashes due to: -eczema   -insect bites   -poison ivy -poison oak   -poison sumac   -soaps -jewelry   -detergents   -cosmetics -psoriasis   -seborrheic dermatitis -for external genital, feminine and anal itching -other uses of this product should be only under the advice and supervision of a doctor stop use and ask a doctor if -symptoms last for more than 7 days -the conditions get worse -symptoms clear up and then occur again within a few days -rectal bleeding occurs

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

zhejiang jingwei pharmaceutical co., ltd. - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), menthyl salicylate, (+/-)- (unii: 43xoa705zd) (salicylic acid - unii:o414pz4lpz) - purpose topical analgesic   temporarily relieves minor aches and pains of muscles and joints associated with: uses -simple backache   -arthritis   -bruises   -strains   -sprains

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

zhejiang jingwei pharmaceutical co., ltd. - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m), zinc acetate (unii: fm5526k07a) (zinc cation - unii:13s1s8sf37) - purpose ---topical analgesic ---skin protectant uses  for temporary relief from pain and itching associated with insect bites, sunburn and minor skin irritations. dries the oozing and weeping of poison: -ivy -oak - sumac do not use -over large areas of the body -with any other product containing diphenhydramine, including those taken orally stop use and ask a doctor if: -symptoms last for more than 7 days -the condition gets worse -symptoms clear up and then occur again within a few days

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

zhejiang jutai pharamceutical co., ltd - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride extended-release tablets (xl) are indicated for the treatment of major depressive disorder (mdd), as defined by the diagnostic and statistical manual (dsm). the efficacy of the immediate-release formulation of bupropion was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult patients with mdd. the efficacy of the sustained-release formulation of bupropion in the maintenance treatment of mdd was established in a long-term (up to 44 weeks), placebo-controlled trial in patients who had responded to bupropion in an 8-week study of acute treatment [see clinical studies (14.1)]. bupropion hydrochloride extended-release tablets (xl) are indicated for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (sad). the efficacy of bupropion hydrochloride extended-release tablets in the prevention of seasonal major depressive episodes was established in 3 placebo-controll

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

zhejiang yongtai pharmaceutical co., ltd. - rosuvastatin calcium (unii: 83mvu38m7q) (rosuvastatin - unii:413kh5zj73) - pediatric use information for patients 7 to 17 years of age is approved for astrazeneca’s crestor (rosuvastatin calcium) tablets. however, due to astrazeneca’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. rosuvastatin calcium tablets are indicated as adjunctive therapy to diet for the treatment of adult patients with hypertriglyceridemia. rosuvastatin calcium tablets are indicated as an adjunct to diet for the treatment of adult patients with primary dysbetalipoproteinemia (type iii hyperlipoproteinemia). rosuvastatin calcium tablets are indicated as adjunctive therapy to other lipid-lowering treatments (e.g., ldl apheresis) or alone if such treatments are unavailable to reduce ldl-c, total-c, and apob in adult patients with homozygous familial hypercholesterolemia. rosuvastatin calcium tablets have not been studied in fredrickson type i and v dyslipidemias. rosuvastatin calcium tablets are contraindicated in the following conditions: rosuvastatin calcium tab

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

zhejiang yongtai pharmaceutical co., ltd - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate and other antibacterial drugs, doxycycline hyclate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections: - rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae. - respiratory tract infections caused by mycoplasma pneumoniae. - lymphogranuloma venereum caused by chlamydia trachomatis . - psittacosis (ornithosis) caused by chlamydophila psittaci . - trachoma caused by chlamydia trachomatis , although the infectious agent is not always el